0000891293-15-000070.txt : 20151218
0000891293-15-000070.hdr.sgml : 20151218
20151218164158
ACCESSION NUMBER: 0000891293-15-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151218
FILED AS OF DATE: 20151218
DATE AS OF CHANGE: 20151218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SINGER JACK W
CENTRAL INDEX KEY: 0001204264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12465
FILM NUMBER: 151297259
MAIL ADDRESS:
STREET 1: 501 ELLIOT AVENUE WEST
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-12-18
0
0000891293
CTI BIOPHARMA CORP
ctic
0001204264
SINGER JACK W
3101 WESTERN AVE
SUITE 600
SEATTLE
WA
98121
1
1
0
0
EVP Global Medical Affairs
Common Stock
2015-12-18
4
S
0
1904
1.17
D
1319946
D
Common Stock
2015-12-18
4
S
0
2000
1.175
D
1317946
D
Common Stock
2015-12-18
4
S
0
10696
1.18
D
1307250
D
Common Stock
2015-12-18
4
S
0
400
1.185
D
1306850
D
The sale was effected pursuant to a Rule 10b5-1 trading plan.
By: Louis A. Bianco, Attorney-in-fact For: Jack W. Singer
2015-12-18